Skip NavigationSkip to Content
Return Return to Search Results

Gene promoter methylation in prostate tumor-associated stromal cells

  1. Author:
    Hanson, J. A.
    Gillespie, J. W.
    Grover, A.
    Tangrea, M. A.
    Chuaqui, R. F.
    Emmert-Buck, M. R.
    Tangrea, J. A.
    Libutti, S. K.
    Linehan, W. M.
    Woodson, K. G.

  2. Author Address

    NCI, Genet Branch, Ctr Canc Res, Ctr Adv Technol,NIH, Bethesda, MD 20892 USA. NCI, Surg Metab Sect, Surg Branch, NIH, Bethesda, MD 20892 USA. NCI, Pathogenet Unit, Pathol Lab, NIH, Bethesda, MD 20892 USA. NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA. NCI, Chemoprevent Branch, NIH, Bethesda, MD 20892 USA. NCI, SAIC Frederick Inc, Frederick, MD 21701 USA.;Woodson, KG, NCI, Genet Branch, Ctr Canc Res, Ctr Adv Technol,NIH, 8717 Grovemont Circle, Bethesda, MD 20892 USA.;kw114v@nih.gov
    1. Year: 2006
    2. Date: Feb
  2. Journal: Journal of the National Cancer Institute
    1. 98
    2. 4
    3. Pages: 255-261
  4. Type of Article: Article
  5. ISSN: 0027-8874
  1. Abstract:

    Background. Gene expression can be silenced through the methylation of specific sites in the promoter region. This mechanism of gene silencing has an important role in the carcinogenesis of prostate and other cancers. Although tumor-associated stromal cells also exhibit changes in gene expression, promoter methylation has not been described in these cells. Methods: Tumor epithelia, tumor-associated stroma and normal epithelia, and stroma adjacent to tumor tissues were isolated from whole-mount prostatectomy specimens (two per patient) of patients (n = 5) with localized prostate cancer and from normal epithelia and stroma from benign prostate hyperplasia specimens (two per patient) from men (n = 5) without prostate cancer by using laser capture microdissection or expression microdissection. The methylation status of three genes important in prostate carcinogenesis, GSTP1, RAR beta 2, and CD44, were evaluated using quantitative methylation-sensitive polymerase chain reaction. Results: GSTP1 and RAR beta 2 were methylated in the tumor epithelium of all five prostate cancer patients and in the tumor-associated stroma in four of the five patients. CD44 was methylated in the tumor epithelium from four of the five patients but not in the tumor stroma. GSTP1 and RAR beta 2 were methylated in normal epithelium of two and four patients, respectively, and in normal stroma of one and two patients, respectively, that were isolated from regions adjacent to the tumors and may have resulted from a tumor-field effect; CD44 methylation was not observed in normal epithelium or stroma. In contrast, normal epithelia and stroma from benign prostate hyperplasia specimens showed no promoter methylation in GSTP1, RAR beta 2, or CD44. Conclusions: The observation of promoter methylation in the non-neoplastic cells of the prostate tumor microenvironment may advance our understanding of prostate cancer development and progression and lead to new diagnostic and prognostic markers and therapeutic targets.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1093/jnci/djj051
  3. View record in Web of Science®
  4. WOS: 000236178300009

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel